Scientists test custom vaccine to turn Kids' own cells against deadly brain cancer
NCT ID NCT03334305
Summary
This early-stage study tested whether a personalized vaccine made from a child's own tumor and immune cells could be safely given to fight aggressive brain cancer. The treatment aimed to train the child's immune system to recognize and attack the cancer cells. The trial was small and terminated early, focusing primarily on safety in children newly diagnosed with high-grade gliomas.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's National Hospital
Washington D.C., District of Columbia, 20010, United States
-
Children's of Alabama at UAB
Birmingham, Alabama, 35233, United States
-
UF Health Shands Children's Hospital
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.